Pulse Biosciences, Inc. (PLSE)
NASDAQ · Healthcare
Pulse Biosciences, Inc. Operating Income 2020–2025
Pulse Biosciences, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Pulse Biosciences, Inc. operating income for the quarter ending March 31, 2026 was -19.1 M, a 6.13% increase year-over-year.
- Pulse Biosciences, Inc. operating income for the twelve months ending March 31, 2026 was -77.8 M, a 64.74% increase year-over-year.
- Pulse Biosciences, Inc. annual operating income for 2025 was -76.9 M, a 36.76% increase from 2024.
- Pulse Biosciences, Inc. annual operating income for 2024 was -56.3 M, a 29.11% increase from 2023.
- Pulse Biosciences, Inc. annual operating income for 2023 was -43.6 M, a 24.95% decrease from 2022.
- Pulse Biosciences, Inc. annual operating income for 2022 was -58.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pulse Biosciences, Inc. Operating Income — FAQ
Pulse Biosciences, Inc. (PLSE) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Pulse Biosciences, Inc.'s operating income?
Pulse Biosciences, Inc. (PLSE) reported operating income of -$77M for fiscal 2025.
Where can I see PLSE's operating income history?
The chart and table above show Pulse Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.